Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Bypass PBM intermediaries for cost-effective, uninterrupted medication access Access branded GLP-1 medications at reduced prices and decide how to share costs with employees Ensure rapid access to GLP-1 medications within 5 days to drive increased persistence anD better health outcomes Higher ROI
Who Is Microdosing Best For
The primary outcome of the trial was the change in A1C from baseline at week 26
How We Think About Quality & Safety Noom is committed to safety and quality
The percentages of participants who experienced AE leading to treatment discontinuation as well as of those who experienced gastrointestinal AE with oral semaglutide 50 mg (Tables 2 and 3) were similar to those observed with subcutaneous semaglutide 2.4 mg (in STEP-1 and STEP-2 trials 67% discontinued treatment due to AE, 3444% experienced nausea, 2132% diarrhoea and 2225% vomiting) [11, 29]
Wegovy contains Semaglutide and is approved for chronic weight management in eligible adults who meet BMI criteria
